Background-Several clinical studies have demonstrated a close association between plasma HDL cholesterol levels and endothelium-dependent vasodilation in peripheral arteries. In isolated arteries, HDL has been shown to mediate vasodilation via NO release. In vivo, administration of reconstituted HDL restored abnormal endothelial function of the brachial artery in hypercholesterolemic patients. However, no data are currently available on the effect of HDL on myocardial perfusion. Methods and Results-In this study, administration of human HDL enhanced incorporation of the perfusion tracer 99m Tc-methoxyisobutylisonitrile ( 99m Tc-MIBI) into the murine heart in vivo by Ϸ18%. This increase was completely abolished in mice deficient for endothelial NO synthase. Because we have recently identified sphingosine 1-phosphate (S1P) as an important vasoactive component contained in HDL, we measured myocardial perfusion after administration of S1P in vivo. We observed an Ϸ25% decrease in myocardial MIBI uptake, which was abolished in mice deficient for the S1P receptor S1P 3 . In S1P 3 Ϫ/Ϫ mice, the stimulatory effect of HDL on myocardial perfusion was preserved. Conclusions-HDL increased myocardial perfusion under basal conditions in vivo via NO-dependent mechanisms, whereas S1P inhibited myocardial perfusion through the S1P 3 receptor. Thus, HDL may reduce coronary risk via direct NO-mediated vasodilatory effects on the coronary circulation. show an inverse relationship between HDL levels and the risk of cardiovascular disease and clinical events. HDL is an independent risk factor in cardiovascular disease, and raising HDL levels alone resulted in a significant risk reduction of major cardiovascular events in patients with coronary disease whose primary lipid abnormality was a low HDL cholesterol level. 1 However, the mechanisms by which HDL exerts its powerful protective effects are still not clear. Among its numerous potential antiatherogenic effects, HDL cholesterol levels are directly associated with flow-mediated vasodilation in clinical patients in vivo, 2 and several experimental studies have shown that HDL directly induces vasodilation through activation of endothelial NO synthase (eNOS) and NO release in isolated arteries ex vivo. 3 Recently, intravenous administration of reconstituted HDL was shown to acutely restore abnormal endothelial function in the brachial artery of hypercholesterolemic patients. 4 In our study we provide evidence that intravenous administration of HDL acutely stimulates myocardial perfusion in vivo in the murine heart via eNOS activation, and we identify the HDL component sphingosine 1-phosphate (S1P) and its receptor S1P 3 as functional opponents of this effect.
Methods
AnimalsMyocardial perfusion was measured in eNOS-deficient (eNOS Ϫ/Ϫ ) mice (nϭ13; aged 18Ϯ1 weeks; weight, 29.3Ϯ02.4 g) 5 as well as in mice deficient for the lysophospholipid receptor S1P 3 (S1P 3 Ϫ/Ϫ ) (nϭ25; aged 24Ϯ12 weeks; weight, 24.1Ϯ3.6 g) and their wild-type (WT) littermates (nϭ24; aged 24Ϯ11 weeks; weight, 25.2...